Gene therapy delivery of Parkin mutants having increased activity to treat Parkinson's disease
Abstract:
The present disclosure provides novel gene therapy constructs comprising a PARK2 gene or activating variant and methods of administering to treat Parkinson's Disease or symptoms thereof.
Information query
Patent Agency Ranking
0/0